8 results
Pulmonary Function Testing (PFT) Interpretation Algorithm

Restrictive Lung Disease:
 • Chest wall or neuromuscular disorders
 • Interstitial
Pulmonary Function ... Testing (PFT) Interpretation ... Algorithm Restrictive ... #Function #Testing ... #Algorithm #diagnosis
Spirometry - PFT Interpretation Algorithm

- BWH Medicine Chiefs @BrighamChiefs

#Spirometry #PFTs #Interpretation #Algorithm #diagnosis #differential #pulmonary #function
Spirometry - PFT Interpretation ... Algorithm - ... #Algorithm #diagnosis ... #differential #pulmonary ... #function #testing
Pulmonary Function Tests (PFTs) - Interpretation Algorithm
 • Normal
 • Pulmonary Hypertension, Anemia, Carboxyhemoglobinemia
 • Chest
Pulmonary Function ... Tests (PFTs) - Interpretation ... Algorithm • Normal ... • Interstitial Lung ... #Algorithm #diagnosis
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment algorithms ... Chronic Obstructive Lung ... limitation, further evaluation ... #Management #Pulmonary ... LAMA #LABA #ICS #Guidelines
Diagnostic algorithm for a child or adolescent with suspected pulmonary hypertension. CHD, congenital heart disease; CPET,
Diagnostic algorithm ... cardiopulmonary exercise testing ... ; CLD, chronic lung ... disease; LFT, liver function ... Hypertension #Workup #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk Evaluation ... Assess functional ... Functional status ... event, follow ACC algorithm ... unless prior heart/lung
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Clinical Practice Guideline ... goals of assessing lung ... a case-by-case basis ... #Algorithm #Effusion ... Management #Pleural #Pulmonary
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... cardiovascular or pulmonary ... Functional defects ... Network (NCCN) guidelines